REQUEST A DEMO
Total
USD $0.00
Search more companies

Bigpharma Distribuciones CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bigpharma Distribuciones CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Bigpharma Distribuciones CIA Ltda is based in Ecuador. The head office is in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 11, 2010. Bigpharma Distribuciones CIA Ltda currently employs 12 (2021) people. In 2022, the company reported a net sales revenue drop of 15.79%. Its total assets decreased by 12.25% over the same period. The enterprise’s net profit margin increased by 2.64% in 2022.

Headquarters
General Duma N45-82
Quito; Pichincha;

Contact Details: Purchase the Bigpharma Distribuciones CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Bigpharma Distribuciones CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Bigpharma Distribuciones CIA Ltda report to view the information.
Registered Capital:
Purchase the Bigpharma Distribuciones CIA Ltda report to view the information.
Incorporation Date:
August 11, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Bigpharma Distribuciones CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.79%
Total operating revenue
-15.79%
Operating profit (EBIT)
17.77%
EBITDA
16.85%
Net Profit (Loss) for the Period
25.42%
Total assets
-12.25%
Total equity
32.73%
Operating Profit Margin (ROS)
3.68%
Net Profit Margin
2.64%
Return on Equity (ROE)
-1.44%
Debt to Equity Ratio
63.82%
Quick Ratio
0.3%
Cash Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?